{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:37:02Z","timestamp":1692956222398},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,1,24]]},"DOI":"10.1253\/circj.cj-19-0667","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T22:04:22Z","timestamp":1576188262000},"page":"161-168","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Guideline-Recommended Risk Score-Directed Dual Antiplatelet Therapy After 2nd-Generation Drug-Eluting Stents"],"prefix":"10.1253","volume":"84","author":[{"given":"Ji-Yong","family":"Jang","sequence":"first","affiliation":[{"name":"Division of Cardiology, National Health Insurance Service Ilsan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Kwon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ho","family":"Shin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"},{"name":"Cardiovascular Research Institute, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Seoul National University Hospital School of Medicine, Seoul National University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Cheol","family":"Gwon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Samsung Medical Centre, Sungkyunkwan University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Seoul National University Hospital School of Medicine, Seoul National University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuck Moon","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine"},{"name":"Cardiovascular Research Institute, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al; ESC Scientific Document Group. 2018 ESC\/EACTS Guidelines on myocardial revascularization. <i>Eur Heart J<\/i> 2019; 40: 87\u2013165.","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. <i>JAMA<\/i> 2007; 297: 159\u2013168.","DOI":"10.1001\/jama.297.2.joc60179"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Raber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, et al. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study. <i>Circulation<\/i> 2012; 125: 1110\u20131121.","DOI":"10.1161\/CIRCULATIONAHA.111.058560"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Palmerini T, Della Riva D, Benedetto U, Bacchi Reggiani L, Feres F, Abizaid A, et al. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: An individual patient data pairwise and network meta-analysis of six randomized trials and 11,473 patients. <i>Eur Heart J<\/i> 2017; 38: 1034\u20131043.","DOI":"10.1093\/eurheartj\/ehw627"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Colombo A, Chieffo A, Frasheri A, Garbo R, Masotti-Centol M, Salvatella N, et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: The SECURITY randomized clinical trial. <i>J Am Coll Cardiol<\/i> 2014; 64: 2086\u20132097.","DOI":"10.1016\/j.jacc.2014.09.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, et al. Effect of intravascular ultrasound-guided vs. angiography-guided everolimus-eluting stent implantation: The IVUS-XPL randomized clinical trial. <i>JAMA<\/i> 2015; 314: 2155\u20132163.","DOI":"10.1001\/jama.2015.15454"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kim BK, Hong MK, Shin DH, Nam CM, Kim JS, Ko YG, et al. A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). <i>J Am Coll Cardiol<\/i> 2012; 60: 1340\u20131348.","DOI":"10.1016\/j.jacc.2012.06.043"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee BK, Kim JS, Lee OH, Min PK, Yoon YW, Hong BK, et al. Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C randomised clinical trial and OCT substudy. <i>EuroIntervention<\/i> 2018; 13: 1923\u20131930.","DOI":"10.4244\/EIJ-D-17-00792"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gwon HC, Hahn JY, Park KW, Song YB, Chae IH, Lim DS, et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. <i>Circulation<\/i> 2012; 125: 505\u2013513.","DOI":"10.1161\/CIRCULATIONAHA.111.059022"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yeh RW, Kereiakes DJ, Steg PG, Windecker S, Rinaldi MJ, Gershlick AH, et al. Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction. <i>J Am Coll Cardiol<\/i> 2015; 5: 2211\u20132221.","DOI":"10.1016\/j.jacc.2015.03.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, et al. Impact of clinical presentation on ischemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: A pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial. <i>Eur Heart J<\/i> 2015; 36: 1242\u20131251.","DOI":"10.1093\/eurheartj\/ehv038"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hahn JY, Song YB, Oh JH, Cho DK, Lee JB, Doh JH, et al. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): A randomized, open-label, non-inferiority trial. <i>Lancet<\/i> 2018; 391: 1274\u20131284.","DOI":"10.1016\/S0140-6736(18)30493-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). <i>Eur Heart J<\/i> 2018; 39: 213\u2013260.","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Costa F, van Klaveren D, James S, Heg D, Raber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials. <i>Lancet<\/i> 2017; 389: 1025\u20131034.","DOI":"10.1016\/S0140-6736(17)30397-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical endpoints in coronary stent trials: A case for standardized definitions. <i>Circulation<\/i> 2007; 115: 2344\u20132351.","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Stone GW, Abizaid A, Onuma Y, Seth A, Gao R, Ormiston J, et al. Effect of technique on outcomes following bioresorbable vascular scaffold implantation: Analysis from the ABSORB trials. <i>J Am Coll Cardiol<\/i> 2017; 70: 2863\u20132874.","DOI":"10.1016\/j.jacc.2017.09.1106"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Giustino G, Chieffo A, Palmerini T, Valgimigli M, Feres F, Abizaid A, et al. Efficacy and safety of dual antiplatelet therapy after complex PCI. <i>J Am Coll Cardiol<\/i> 2016; 68: 1851\u20131864.","DOI":"10.1016\/j.jacc.2016.07.760"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Palmerini T, Della Riva D, Biondi-Zoccai G, Leon MB, Serruys PW, Smits PC, et al. Mortality Following nonemergent, uncomplicated target lesion revascularization after percutaneous coronary intervention: An individual patient data pooled analysis of 21 randomized trials and 32,524 patients. <i>JACC Cardiovasc Interv<\/i> 2018; 11: 892\u2013902.","DOI":"10.1016\/j.jcin.2018.01.277"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kupka D, Sibbing D. de-escalation of p2y12 receptor inhibitor therapy after acute coronary syndromes in patients undergoing percutaneous coronary intervention. <i>Korean Circ J<\/i> 2018; 48: 863\u2013872.","DOI":"10.4070\/kcj.2018.0255"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Costa F, Van Klaveren D, Feres F, James S, R\u00e4ber L, Pilgrim T, et al. Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. <i>J Am Coll Cardiol<\/i> 2019; 73: 741\u2013754.","DOI":"10.1016\/j.jacc.2018.11.048"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. <i>Lancet<\/i> 2013; 382: 1714\u20131722.","DOI":"10.1016\/S0140-6736(13)61720-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. <i>JAMA<\/i> 2014; 311: 836\u2013843.","DOI":"10.1001\/jama.2014.980"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. <i>Thromb Haemost<\/i> 2008; 99: 930\u2013935.","DOI":"10.1160\/TH08-01-0002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vranckx P, Valgimigli M, Juni P, Hamm C, Steg PG, Heg D, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs. aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: A multicentre, open-label, randomised superiority trial. <i>Lancet<\/i> 2018; 392: 940\u2013949.","DOI":"10.1016\/S0140-6736(18)31858-0"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/2\/84_CJ-19-0667\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T03:23:01Z","timestamp":1579922581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/2\/84_CJ-19-0667\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0667","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]}}}